Read more
5:15 PM · 4 March 2025

📉US100 drops 1%

The declines on the US stock market are accelerating, and after yesterday's weakest session this year for the S&P 500, the US500 index is losing almost 0.9%. The biggest decline is visible in the Nasdaq 100 (US100) quotations, where we see a sell-off of over 1%, before the market opens.

  • Before the opening of Wall Street, Nvidia is losing over 3%, where the declines indicate an opening around USD 110 per share. Tesla shares are losing almost 4%, whose EV model sales in China fell by almost 49% year-on-year. The VIX volatility index has risen by over 5%.
  • Before the US session, retailer Target (TGT.US) shares are also losing, whose profits and revenues - although they exceeded expectations, forecasts fell short. The company expects flat comparable sales this year, while the market was counting on around 1.7% growth. It also reported additional costs resulting from tariffs.
  • Investors still seem to be reacting to the recent mixed US economic data, which indicates rising inflation expectations, while consumer sentiment and retail sales are weaker. Yesterday’s ISM manufacturing report also pointed to a higher price index, while orders and employment were weak.
  • Investors are pricing in weaker US data as likely to prompt the Fed to cut as many as three times this year. At the same time, a risky stagflation scenario is causing investors to withdraw risky assets, including from technology stocks. Nasdaq (US100) futures fell below the EMA200, indicating a very important test of trend strength.

US100 (D1 interval)

Source: xStation5

17 April 2026, 8:04 PM

Three Markets To Watch (20.04.2026)

17 April 2026, 6:43 PM

Parabolic rallies on European markets ahead of the weekend💡

17 April 2026, 5:34 PM

US OPEN: The Strait of Hormuz is fully open 💥Euphoria in the markets 🚀

17 April 2026, 2:09 PM

Market wrap: Peace rumours and disapointing earnings

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.